AFT to defend PBL Solutions lawsuit

AFT to defend PBL Solutions lawsuit
Staff reporters
AFT Pharmaceuticals will vigorously defend a claim by joint venture partner PBL Solutions that the Kiwi firm breached its contract in the development of the Pascomer topical treatment. PBL filed proceedings in the New Zealand High Court against AFT and managing director Hartley Atkinson, seeking an account of AFT’s present and future profits from Pascomer, or yet to be quantified damages. AFT owns 65 percent of AFT Orphan Pharmaceuticals, and PBL owns the balance. AFT said it’s spent more than $5.6 million developing the d...